Cited by 642Migraine and Headache StudiesMusculoskeletal pain and rehabilitationTemporomandibular Joint Disorders

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Migraine is first cause of disability in under 50s: will health politicians now take notice?

Open access

Steiner, Timothy J., Stovner, Lars J., Vos, Theo, Jensen, R., Katsarava, Z.·2018·The Journal of Headache and Pain

DOI 10.1186/s10194-018-0846-2PMC PMC5821623

Open this paper in CoChat — free account Open PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/s10194-018-0846-2

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citation
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Arnold, M. (2018) · Cephalalgia · doi:10.1177/0333102417738202 · Cited by 11,090
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Self-citation
The International Classification of Headache Disorders, 3rd edition (beta version)
Headache Classification Committee of the International Headache Society (IHS) (2013) · Cephalalgia · doi:10.1177/0333102413485658 · Cited by 8,229
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Self-citation
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Self-citation
The global burden of headache: A documentation of headache prevalence and disability worldwide
Stovner, L., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A., Steiner, T., & Zwart, J.-A. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01288.x · Cited by 2,444
Self-citation
World Health Report
Prentice, T. (2013) · Res Medica · doi:10.2218/resmedica.v21i1.510 · Cited by 1,710
The World Health Report 2001
Bebbington, P. (2001) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270170010 · Cited by 515
The impact of headache in Europe: principal results of the Eurolight project
Steiner, T. J., Stovner, L. J., Katsarava, Z., Lainez, J. M., Lampl, C., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Tassorelli, C., Barré, J., et al. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-31 · Cited by 382 · cited 2×
“A considerable strength of this study, apart from its size and geographical scope, was the use in all countries of the same questionnaire [12], a derivative of the HARDSHIP questionnaire already employed in many different countries, cultures and translations [13].”
MethodSelf-citation

Show all 32 references

Research works printed but not linked: 2

The Lancet, at http://www.thelancet.com/gbd (Accessed 15 January 2018)
Steiner TJ, Paemeleire K, Jensen R, Valade D, Savi L, Lainez MJA, Diener H-C, Martelletti P, Couturier EGM (2007) European principles of management of common headache disorders in primary care. J Headache Pain 8(suppl 1):S3–S21

Sorted by citations

Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Stovner, L. J., Nichols, E., Steiner, T. J., Abd-Allah, F., Abdelalim, A., Al-Raddadi, R. M., Ansha, M. G., Barac, A. M., Benseñor, I. M., Doan, L. P., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30322-3 · Cited by 1,975
Self-citation
Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019
Headache, O. B. O. L. T. B. T. G. C. A., Steiner, T. J., Stovner, L. J., Jensen, R., Uludüz, D., & Katsarava, Z. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01208-0 · Cited by 1,049
Self-citation
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
Ferrari, M. D., Diener, H., Ning, X., Galić, M., Cohen, J. M., Yang, R., Müeller, M., Ahn, A. H., Schwartz, Y. C., Grozinski‐Wolff, M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31946-4 · Cited by 416
Gut-brain Axis and migraine headache: a comprehensive review
On behalf of the School of Advanced Studies of the European Headache Federation (EHF-SAS), Arzani, M., Jahromi, S. R., Ghorbani, Z., Vahabizad, F., Martelletti, P., Ghaemi, A., Sacco, S., & Togha, M. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-1078-9 · Cited by 366
Migraine: integrated approaches to clinical management and emerging treatments
Ashina, M., Buse, D. C., Ashina, H., Pozo‐Rosich, P., Peres, M. F. P., Lee, M. J., Terwindt, G. M., Singh, R. B. H., Tassorelli, C., Do, T. P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32342-4 · Cited by 311
A narrative review on the burden of migraine: when the burden is the impact on people’s life
Leonardi, M., & Raggi, A. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0993-0 · Cited by 303
Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications
Dresler, T., Caratozzolo, S., Guldolf, K., Huhn, J.-I., Loiacono, C., Niiberg-Pikksööt, T., Puma, M., Sforza, G., Tobia, A., Ornello, R., et al. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0988-x · Cited by 253
My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed
Martelletti, P., Schwedt, T. J., Lanteri-Minet, M., Quintana, R., Carboni, V., Diener, H.-C., Ruiz de la Torre, E., Craven, A., Rasmussen, A. V., Evans, S., et al. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0946-z · Cited by 217
Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial
Xu, S., Yu, L., Luo, X., Wang, M., Chen, G., Zhang, Q., Liu, W., Zhou, Z., Song, J., Jing, H.-T., et al. (2020) · BMJ · doi:10.1136/bmj.m697 · Cited by 223
Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans
de Vries, T., Villalón, C. M., & MaassenVanDenBrink, A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107528 · Cited by 227
Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models
Avona, A., Burgos-Vega, C., Burton, M. D., Akopian, A. N., Price, T. J., & Dussor, G. O. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0364-19.2019 · Cited by 196
Hormonal influences in migraine — interactions of oestrogen, oxytocin and CGRP
Krause, D. N., Warfvinge, K., Haanes, K. A., & Edvinsson, L. I. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00544-2 · Cited by 214
The effect of aerobic exercise on the number of migraine days, duration and pain intensity in migraine: a systematic literature review and meta-analysis
Lemmens, J., Pauw, J. D., Soom, T. V., Michiels, S., Versijpt, J. J., van Breda, E., Castien, R., & Hertogh, W. D. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0961-8 · Cited by 184
Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences
Lipton, R. B., Munjal, S., Alam, A., Buse, D. C., Fanning, K. M., Reed, M. L., Schwedt, T. J., & Dodick, D. W. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13407 · Cited by 187
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
Ornello, R., Casalena, A., Frattale, I., Gabriele, A., Affaitati, G., Giamberardino, M. A., Assetta, M., Maddestra, M., Marzoli, F., Viola, S., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01102-9 · Cited by 167
Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
Messina, R., Huessler, E., Puledda, F., Haghdoost, F., Lebedeva, E. R., & Diener, H. (2023) · Cephalalgia · doi:10.1177/03331024231152169 · Cited by 155
Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom
Vo, P. G., Fang, J., Bilitou, A., Laflamme, A. K., & Gupta, S. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0907-6 · Cited by 157
Association of diet and headache
Jahromi, S. R., Ghorbani, Z., Martelletti, P., Lampl, C., & Togha, M. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1057-1 · Cited by 151
Current understanding of meningeal and cerebral vascular function underlying migraine headache
Levy, D., Labastida‐Ramírez, A., & MaassenVanDenBrink, A. (2018) · Cephalalgia · doi:10.1177/0333102418771350 · Cited by 130
Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort
Viana, M., Khaliq, F., Zecca, C., Figuerola, M. D. L., Sances, G., Piero, V. D., Petolicchio, B., Alessiani, M., Geppetti, P., Lupi, C., et al. (2019) · European Journal of Neurology · doi:10.1111/ene.14098 · Cited by 125
Efficacy of psychological treatment for headache disorder: a systematic review and meta-analysis
Lee, H. J., Lee, J. H., Cho, E. Y., Kim, S. M., & Yoon, S. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0965-4 · Cited by 108
Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs
Hansen, J. M., & Charles, A. C. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1046-4 · Cited by 97
Meningeal CGRP ‐Prolactin Interaction Evokes Female‐Specific Migraine Behavior
Avona, A., Mason, B. N., Burgos-Vega, C., Hovhannisyan, A. H., Belugin, S., Mecklenburg, J. M., Goffin, V., Wajahat, N., Price, T. J., Akopian, A. N., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26070 · Cited by 97
Content Validity of HIT‐6 as a Measure of Headache Impact in People With Migraine: A Narrative Review
Houts, C. R., Wirth, R. J., McGinley, J. S., Gwaltney, C. J., Kassel, E., Snapinn, S. M., & Cady, R. K. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13701 · Cited by 105
The role of nutrients in the pathogenesis and treatment of migraine headaches: Review
Nattagh‐Eshtivani, E., Sani, M. A., Dahri, M., Ghalichi, F., Ghavami, A., Arzhang, P., & Tarighat‐Esfanjani, A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.059 · Cited by 92
Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre
Negro, A., Sciattella, P., Rossi, D., Guglielmetti, M., Martelletti, P., & Mennini, F. S. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1068-y · Cited by 89
Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis
Drellia, K., Kokoti, L., Deligianni, C. I., Papadopoulos, D., & Mitsikostas, D. D. (2021) · Cephalalgia · doi:10.1177/0333102421989601 · Cited by 88
Co-occurrence of pain syndromes
Affaitati, G., Costantini, R., Tana, C., Cipollone, F., & Giamberardino, M. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02107-8 · Cited by 99
Physical therapy and migraine: musculoskeletal and balance dysfunctions and their relevance for clinical practice
Carvalho, G. F., Schwarz, A., Szikszay, T. M., Adamczyk, W. M., Bevilaqua‐Grossi, D., & Luedtke, K. (2019) · Brazilian Journal of Physical Therapy · doi:10.1016/j.bjpt.2019.11.001 · Cited by 91
Vitamin D in migraine headache: a comprehensive review on literature
Ghorbani, Z., Togha, M., Rafiee, P., Ahmadi, Z. S., Rasekhmagham, R., Haghighi, S., Jahromi, S. R., & Mahmoudi, M. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04021-z · Cited by 83
Botulinum Toxin in the Treatment of Headache
Becker, W. J. (2020) · Toxins · doi:10.3390/toxins12120803 · Cited by 81
The prevalence of primary headache disorders in Saudi Arabia: a cross-sectional population-based study
Jumah, M. A., Khathaami, A. M. A., Kojan, S., Hussain, M., Thomas, H., & Steiner, T. J. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-1081-1 · Cited by 80
Self-citation
Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application
Vo, P. G., Paris, N., Bilitou, A., Valena, T., Fang, J., Naujoks, C., Cameron, A. E., de Vulpillieres, F. D. R., & Cadiou, F. (2018) · Neurology and Therapy · doi:10.1007/s40120-018-0113-0 · Cited by 76
Headache in Children and Adolescents
Szperka, C. L. (2021) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000993 · Cited by 77
Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
Moore, E. L., Fraley, M. E., Bell, I. M., Burgey, C. S., White, R. B., Li, C., Regan, C. P., Danziger, A., Michener, M. S., Hostetler, E. D., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.261065 · Cited by 76
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
Scuteri, D., Adornetto, A., Rombolà, L., Naturale, M. D., Morrone, L. A., Bagetta, G., Tonin, P., & Corasaniti, M. T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00363 · Cited by 74
An investigation of oxidant/antioxidant balance in patients with migraine: a case-control study
Togha, M., Jahromi, S. R., Ghorbani, Z., Ghaemi, A., & Rafiee, P. (2019) · BMC Neurology · doi:10.1186/s12883-019-1555-4 · Cited by 73
Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description
Steiner, T. J., Jensen, R., Katsarava, Z., Stovner, L. J., Uludüz, D., Adarmouch, L., Jumah, M. A., Khathaami, A. M. A., Ashina, M., Braschinsky, M., et al. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01265-z · Cited by 72
Self-citation
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial
Yu, S., Kim, B., Guo, A., Kim, M., Zhang, M., Wang, Z., Liu, J., Moon, H., Tan, G., Yang, Q., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00126-6 · Cited by 71
Migraine management: Non-pharmacological points for patients and health care professionals
Haghdoost, F., & Togha, M. (2022) · Open Medicine · doi:10.1515/med-2022-0598 · Cited by 70
Global, regional, and national burden and trends of migraine among youths and young adults aged 15–39 years from 1990 to 2021: findings from the global burden of disease study 2021
Chen, Z., Kong, X.-M., Yang, C., Li, X., Guo, H. Y., & Wang, Z. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01832-0 · Cited by 68
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives
Matteis, E. D., Guglielmetti, M., Ornello, R., Spuntarelli, V., Martelletti, P., & Sacco, S. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1772758 · Cited by 70
GBD2021: headache disorders and global lost health – a focus on children, and a view forward
Steiner, T. J., Husøy, A. K., & Stovner, L. J. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01795-2 · Cited by 65
Self-citation
Acute headache management in emergency department. A narrative review
Giamberardino, M. A., Affaitati, G., Costantini, R., Guglielmetti, M., & Martelletti, P. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-019-02266-2 · Cited by 64
The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study
Waliszewska‐Prosół, M., Montisano, D. A., Antolak, M., Bighiani, F., Cammarota, F., Cetta, I., Corrado, M., Ihara, K., Kartamysheva, R., Petrušić, I., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01735-0 · Cited by 66
Migraine, Brain Glucose Metabolism and the “Neuroenergetic” Hypothesis: A Scoping Review
Moro, L. D., Rota, E., Pirovano, E., & Rainero, I. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.02.006 · Cited by 66
The Study of Pain in Rats and Mice
Larson, C. M., Wilcox, G. L., & Fairbanks, C. A. (2019) · Comparative Medicine · doi:10.30802/aalas-cm-19-000062 · Cited by 61
Migraine Pathophysiology
Qubty, W. F., & Patniyot, I. R. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.12.014 · Cited by 61
Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide
Loomis, C. M., Dutzar, B., Ojala, E. W., Hendrix, L., Karasek, C., Scalley-Kim, M. L., Mulligan, J., Fan, P., Billgren, J., Rubin, V., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.253443 · Cited by 59
Using Sleep Time Data from Wearable Sensors for Early Detection of Migraine Attacks
Siirtola, P., Koskimäki, H., Mönttinen, H., & Röning, J. (2018) · Sensors · doi:10.3390/s18051374 · Cited by 57
Migraine in the workplace
de Dhaem, O. B., & Sakai, F. (2022) · eNeurologicalSci · doi:10.1016/j.ensci.2022.100408 · Cited by 56
Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine—a meta-analysis
Sazali, S., Badrin, S., Norhayati, M. N., & Idris, N. S. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-039358 · Cited by 54
Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort
Waliszewska‐Prosół, M., Straburzyński, M., Czapińska-Ciepiela, E., Nowaczewska, M., Gryglas‐Dworak, A., & Budrewicz, S. P. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01575-4 · Cited by 54
Heartrate variability biofeedback for migraine using a smartphone application and sensor: A randomized controlled trial
Minen, M. T., Corner, S. E., Berk, T., Levitan, V., Friedman, S., Adhikari, S., & Seng, E. (2021) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.12.008 · Cited by 53
Current clinical practice in disabling and chronic migraine in the primary care setting: results from the European My-LIFE anamnesis survey
Ryvlin, P., Владимирович, С. К., Negro, A., la Rosa, R. S.-D., Israel-Willner, H., Sundal, C., MacGregor, E. A., & Peral, Á. L. G. (2021) · BMC Neurology · doi:10.1186/s12883-020-02014-6 · Cited by 53
Pharmacologic Characterization of ALD403, a Potent Neutralizing Humanized Monoclonal Antibody Against the Calcitonin Gene-Related Peptide
Garcı́a-Martı́nez, L. F., Raport, C. J., Ojala, E. W., Dutzar, B., Anderson, K., Stewart, E., Kovacevich, B. R., Baker, B., Billgren, J., Scalley-Kim, M. L., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.264671 · Cited by 52
Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis
Giri, S., Tronvik, E., Linde, M., Pedersen, S. A., & Hagen, K. (2023) · Cephalalgia · doi:10.1177/03331024231156922 · Cited by 52
Non-Pharmacological Approaches to Headaches: Non-Invasive Neuromodulation, Nutraceuticals, and Behavioral Approaches
Grazzi, L., Toppo, C., D’Amico, D., Leonardi, M., Martelletti, P., Raggi, A., & Guastafierro, E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041503 · Cited by 55
United States Patients’ Perspective of Living With Migraine: Country‐Specific Results From the Global “My Migraine Voice” Survey
Gibbs, S. N., Shah, S., Deshpande, C. G., Bensink, M. E., Broder, M. S., Dumas, P. K., Buse, D. C., Vo, P., & Schwedt, T. J. (2020) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13829 · Cited by 50
A causal effects of gut microbiota in the development of migraine
He, Q., Wang, W., Xiong, Y., Tao, C., Ma, L., Ma, J., You, C., Anttila, V., Artto, V., Belin, A. C., et al. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01609-x · Cited by 52
Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial
Ghorbani, Z., Togha, M., Rafiee, P., Ahmadi, Z. S., Rasekhmagham, R., Djalali, M., Shahemi, S., Martami, F., Zareei, M., Jahromi, S. R., et al. (2020) · Neurological Sciences · doi:10.1007/s10072-019-04220-8 · Cited by 51
Quality of life of migraine patients followed in neurology clinics in Riyadh, Saudi Arabia
Al-Ateeq, M., & AlHarbi, F. (2020) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_185_19 · Cited by 51
Vancouver Declaration on Global Headache Patient Advocacy 2018
Dodick, D. W., Edvinsson, L. I., Makino, T., Grisold, W., Sakai, F., Jensen, R., Balch, A. J., de la Torre, E. R., Lorenz, D. H., Craven, A., et al. (2018) · Cephalalgia · doi:10.1177/0333102418781644 · Cited by 50
Self-citation
Structured headache services as the solution to the ill-health burden of headache. 3. Modelling effectiveness and cost-effectiveness of implementation in Europe: findings and conclusions
Tinelli, M., Leonardi, M., Paemeleire, K., Raggi, A., Mitsikostas, D. D., de la Torre, E. R., & Steiner, T. J. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01305-8 · Cited by 50
Self-citation
Ubrogepant for the treatment of migraine
Curto, M., Capi, M., Cipolla, F., Cisale, G. Y., Martelletti, P., & Lionetto, L. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1721462 · Cited by 49
Headache in the Global Burden of Disease (GBD) Studies
Stovner, L. J., Nichols, E. L., Steiner, T. J., & Vos, T. (2019) · Headache · doi:10.1007/978-3-030-24728-7_9 · Cited by 48
Self-citation
The Global Campaign turns 18: a brief review of its activities and achievements
Steiner, T. J., Birbeck, G. L., Jensen, R., Martelletti, P., Stovner, L. J., Uludüz, D., Leonardi, M., Olesen, J., & Katsarava, Z. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01420-0 · Cited by 46
Self-citation
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Smith, T. R., Spierings, E. L. H., Cady, R. K., Hirman, J., Schaeffler, B. A., Shen, V., Sperling, B., Brevig, T., Josiassen, M. K., Brunner, E., et al. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01227-5 · Cited by 46
Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study
Pozo‐Rosich, P., Lucas, C., Watson, D. P. B., Gaul, C., Ramsden, E., Ritter, S., Martelletti, P., & Snellman, J. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00331-3 · Cited by 45
Prolactin signaling modulates stress‐induced behavioral responses in a preclinical mouse model of migraine
Mason, B. N., Kallianpur, R., Price, T. J., Akopian, A. N., & Dussor, G. O. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14248 · Cited by 50
Monitoring chronic headache and medication-overuse headache prevalence in Denmark
Westergaard, M. L., Lau, C. J., Allesøe, K., Gjendal, S. T., & Jensen, R. H. (2020) · Cephalalgia · doi:10.1177/0333102419876909 · Cited by 44
Self-citation
Acute sleep deprivation enhances susceptibility to the migraine substrate cortical spreading depolarization
Negro, A., Seidel, J. L., Houben, T., Yu, E. S., Rosen, I., Arreguin, A. J., Yalcin, N., Shorser-Gentile, L., Pearlman, L., Sadhegian, H., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01155-w · Cited by 45
Cortical spreading depression and meningeal nociception
Carneiro-Nascimento, S., & Levy, D. (2022) · Neurobiology of Pain · doi:10.1016/j.ynpai.2022.100091 · Cited by 43
Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials
Loo, L. S., Ailani, J., Schim, J. D., Baygani, S., Hundemer, H., Port, M. D., & Krege, J. H. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1032-x · Cited by 43
Assessment of peripheral biomarkers potentially involved in episodic and chronic migraine: a case-control study with a focus on NGF, BDNF, VEGF, and PGE2
Mozafarihashjin, M., Togha, M., Ghorbani, Z., Farbod, A., Rafiee, P., & Martami, F. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01377-6 · Cited by 43
Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care
Korolainen, M. A., Kurki, S. H., Lassenius, M. I., Toppila, I., Costa‐Scharplatz, M., Purmonen, T. T., & Nissilä, M. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0964-5 · Cited by 42
Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants
Ankrom, W., Xu, J., Vallee, M., Dockendorf, M. F., Armas, D. R., Boinpally, R., & Min, K. C. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1610 · Cited by 42
Headache service quality: the role of specialized headache centres within structured headache services, and suggested standards and criteria as centres of excellence
on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache, Steiner, T. J., Göbel, H., Jensen, R., Lampl, C., Paemeleire, K., Linde, M., Braschinsky, M., Mitsikostas, D. D., Gil‐Gouveia, R., et al. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0970-7 · Cited by 42
Self-citation
Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment
Gazerani, P. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00428-8 · Cited by 42
Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study
Lipton, R. B., Lombard, L., Ruff, D. D., Krege, J. H., Loo, L. S., Buchanan, A. S., Melby, T. E., & Buse, D. C. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01088-4 · Cited by 42
Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
Driessen, M. T., Cohen, J. M., Thompson, S. F., Patterson‐Lomba, O., Seminerio, M. J., Carr, K., Totev, T. I., Sun, R., Yim, E., Mu, F., et al. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01415-x · Cited by 42
Effect of fremanezumab on quality of life and productivity in patients with chronic migraine
Lipton, R. B., Cohen, J. M., Gandhi, S. K., Yang, R., Yeung, P. P., & Buse, D. C. (2020) · Neurology · doi:10.1212/wnl.0000000000010000 · Cited by 41
Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
Martelletti, P., Edvinsson, L. I., & Ashina, M. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1009-9 · Cited by 40
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process
Steiner, T. J., Terwindt, G. M., Katsarava, Z., Pozo-Rosich, P., Gantenbein, A. R., Roche, S. L., Dell’Agnello, G., & Tassorelli, C. (2022) · Cephalalgia · doi:10.1177/03331024221110102 · Cited by 39
Self-citation
Manual joint mobilisation techniques, supervised physical activity, psychological treatment, acupuncture and patient education in migraine treatment. A systematic review and meta-analysis
Beier, D., Edemann-Callesen, H., Carlsen, L. N., Birkefoss, K., Tómasdóttir, H., Würtzen, H., Christensen, H. W., Krøll, L. S., Jensen, M. T., Høst, C. V., et al. (2021) · Cephalalgia · doi:10.1177/03331024211034489 · Cited by 39
Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine
Hellenic Headache Society, Kouremenos, E., Arvaniti, C., Constantinidis, T. S., Giannouli, E., Fakas, N., Kalamatas, T., Kararizou, E. G., Naoumis, D., & Mitsikostas, D. D. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1060-6 · Cited by 39
The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial
Ghorbani, Z., Rafiee, P., Fotouhi, A., Haghighi, S., Rasekhmagham, R., Ahmadi, Z. S., Djalali, M., Zareei, M., Jahromi, S. R., Shahemi, S., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01090-w · Cited by 39
A rational approach to migraine diagnosis and management in primary care
Martin, V. T., Feoktistov, A., & Solomon, G. D. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1995626 · Cited by 38
Efficacy and Safety of Rimegepant 75 mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial
Lipton, R. B., Thiry, A., Morris, B., & Croop, R. S. (2024) · Journal of Pain Research · doi:10.2147/jpr.s453806 · Cited by 38
Burden of migraine and unmet needs from the patients’ perspective: a survey across 11 specialized headache clinics in Korea
Kim, B., Chu, M. K., Yu, S. J., Dell’Agnello, G., Han, J. H., & Cho, S. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01250-6 · Cited by 38
Baseline Brain Gray Matter Volume as a Predictor of Acupuncture Outcome in Treating Migraine
Yang, X., Liu, L., Xu, Z., Zhang, Y., Liu, D., Fishers, M., Zhang, L., Sun, J., Liu, P., Zeng, X., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00111 · Cited by 37
Acupuncture and Its Role in the Treatment of Migraine Headaches
Urits, I., Patel, M., Putz, M. E., Monteferrante, N. R., Nguyen, D., An, D., Cornett, E. M., Hasoon, J. J., Kaye, A. D., & Viswanath, O. (2020) · Neurology and Therapy · doi:10.1007/s40120-020-00216-1 · Cited by 37
Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults
Min, K. C., Kraft, W. K., Bondiskey, P., Colón‐González, F., Liu, W., Xu, J., Panebianco, D. L., Mixson, L. A., Dockendorf, M. F., Matthews, C. Z., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12917 · Cited by 36
miR‐34a‐5p up‐regulates the IL‐1β/COX2/PGE2 inflammation pathway and induces the release of CGRP via inhibition of SIRT1 in rat trigeminal ganglion neurons
Zhang, H., Zhang, X., Zong, D., Ji, X., Jiang, H., Zhang, F., & He, S. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.13027 · Cited by 36
Measurement properties of the Headache Impact Test (HIT‐6™ Brazil) in primary and secondary headaches
Pradela, J., Bevilaqua‐Grossi, D., Chaves, T. C., Dach, F., & Carvalho, G. F. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14049 · Cited by 41
Astrocytes mediate migraine-related intracranial meningeal mechanical hypersensitivity
Zhao, J., Blaeser, A. S., & Levy, D. (2021) · Pain · doi:10.1097/j.pain.0000000000002229 · Cited by 35
Structured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodology
Tinelli, M., Leonardi, M., Paemeleire, K., Mitsikostas, D. D., de la Torre, E. R., & Steiner, T. J. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01310-x · Cited by 36
Self-citation
Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response
Marcus, S. C., Shewale, A. R., Silberstein, S. D., Lipton, R. B., Young, W. B., Viswanathan, H. N., & Doshi, J. A. (2020) · Cephalalgia · doi:10.1177/0333102420915167 · Cited by 35
The socioeconomic burden of migraine: An evaluation of productivity losses due to migraine headaches based on a population study in Germany
Seddik, A. H., Branner, J. C., Ostwald, D. A., Schramm, S. H., Bierbaum, M., & Katsarava, Z. (2020) · Cephalalgia · doi:10.1177/0333102420944842 · Cited by 34
Self-citation
Effectiveness of a manual therapy protocol based on articulatory techniques in migraine patients. A randomized controlled trial
Muñoz‐Gómez, E., Inglés, M., Serra‐Añó, P., & Espí‐López, G. V. (2021) · Musculoskeletal Science and Practice · doi:10.1016/j.msksp.2021.102386 · Cited by 34

Authors: Steiner, T. J., Stovner, L. J., Vos, T., Jensen, R., & Katsarava, Z.
Affiliations: Norwegian University of Science and Technology (NO)
University of Washington (US)
University of Copenhagen (DK)
University of Duisburg-Essen (DE)
Corresponding author: Steiner, Timothy J.
ORCID: Steiner, Timothy J.
Stovner, Lars J.
Vos, Theo
Jensen, R.
Katsarava, Z.
Venue: The Journal of Headache and Pain
Publisher: Springer Science and Business Media LLC
Published: 2018-02-21
Volume: 19
Issue: 1
Pages: 17-17
ISSN: 1129-2369 (ISSN-L)
1129-2377
DOI: 10.1186/s10194-018-0846-2
PMC: PMC5821623
OpenAlex: W2788340920
Cited by: 642
References: 32
Citations by year: 2026: 38 · 2025: 58 · 2024: 96 · 2023: 66 · 2022: 85 · 2021: 99 · 2020: 91 · 2019: 82 · 2018: 26
FWCI: 58.63
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
Locations: The Journal of Headache and Pain (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion, cc-by)
Spiral (Imperial College London) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
Keywords: migraine, disability, young adults, health policy, disease burden

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Migraine is first cause of disability in under 50s: will health politicians now take notice?

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks